glycerol has been researched along with Citrullinemia in 5 studies
Moon: The natural satellite of the planet Earth. It includes the lunar cycles or phases, the lunar month, lunar landscapes, geography, and soil.
Citrullinemia: A group of diseases related to a deficiency of the enzyme ARGININOSUCCINATE SYNTHASE which causes an elevation of serum levels of CITRULLINE. In neonates, clinical manifestations include lethargy, hypotonia, and SEIZURES. Milder forms also occur. Childhood and adult forms may present with recurrent episodes of intermittent weakness, lethargy, ATAXIA, behavioral changes, and DYSARTHRIA. (From Menkes, Textbook of Child Neurology, 5th ed, p49)
Excerpt | Relevance | Reference |
---|---|---|
"We report a risk of worsening of encephalopathy by glycerol infusion when this osmotic agent is used for the treatment of brain edema in patients with adult-onset type II citrullinemia (CTLN2) caused by citrin deficiency." | 7.73 | Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adult-onset type II citrullinemia (CTLN2). ( Ikeda, S; Kobayashi, K; Saheki, T; Takei, Y; Yazaki, M, 2005) |
"We report a risk of worsening of encephalopathy by glycerol infusion when this osmotic agent is used for the treatment of brain edema in patients with adult-onset type II citrullinemia (CTLN2) caused by citrin deficiency." | 3.73 | Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adult-onset type II citrullinemia (CTLN2). ( Ikeda, S; Kobayashi, K; Saheki, T; Takei, Y; Yazaki, M, 2005) |
"Physicians should take CTLN2 into consideration as a differential diagnosis in Asian patients with a history of repeated unconsciousness with hyperammonemia and use D-mannitol but not glycerol to treat brain edema in patients with CTLN2." | 3.73 | A case of adult-onset type II citrullinemia--deterioration of clinical course after infusion of hyperosmotic and high sugar solutions. ( Begum, L; Hirabayashi, H; Kagawa, T; Kobayashi, K; Mine, T; Saheki, T; Shinohara, Y; Takagi, S; Takahashi, H; Yui, M, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Saheki, T | 3 |
Inoue, K | 1 |
Ono, H | 1 |
Fujimoto, Y | 1 |
Furuie, S | 1 |
Yamamura, KI | 1 |
Kuroda, E | 1 |
Ushikai, M | 1 |
Asakawa, A | 1 |
Inui, A | 1 |
Eto, K | 1 |
Kadowaki, T | 1 |
Moriyama, M | 1 |
Sinasac, DS | 1 |
Yamamoto, T | 1 |
Furukawa, T | 1 |
Kobayashi, K | 3 |
Yazaki, M | 1 |
Takei, Y | 1 |
Ikeda, S | 3 |
Takahashi, H | 1 |
Kagawa, T | 1 |
Hirabayashi, H | 1 |
Yui, M | 1 |
Begum, L | 1 |
Mine, T | 1 |
Takagi, S | 1 |
Shinohara, Y | 1 |
2 reviews available for glycerol and Citrullinemia
Article | Year |
---|---|
[Adult-onset citrullinemia].
Topics: Administration, Oral; Age of Onset; Arginine; Argininosuccinate Synthase; Calcium-Binding Proteins; | 2007 |
[Adult-onset citrullinemia].
Topics: Administration, Oral; Adult; Age of Onset; Arginine; Argininosuccinate Synthase; Calcium-Binding Pro | 2007 |
3 other studies available for glycerol and Citrullinemia
Article | Year |
---|---|
Oral aversion to dietary sugar, ethanol and glycerol correlates with alterations in specific hepatic metabolites in a mouse model of human citrin deficiency.
Topics: Adenosine Triphosphate; Amino Acid Transport Systems, Acidic; Animals; Antiporters; Citrullinemia; D | 2017 |
Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adult-onset type II citrullinemia (CTLN2).
Topics: Adult; Age of Onset; Brain Edema; Calcium-Binding Proteins; Citrullinemia; Disease Progression; Diur | 2005 |
A case of adult-onset type II citrullinemia--deterioration of clinical course after infusion of hyperosmotic and high sugar solutions.
Topics: Adult; Brain Edema; Citrullinemia; Diagnosis, Differential; Fatal Outcome; Fructose; Glycerol; Human | 2006 |